» Articles » PMID: 28416008

A Guide to Acquired Vitamin K Coagulophathy Diagnosis and Treatment: the Russian Perspective

Abstract

Physicians often come across with cases of vitamin K antagonists-dependent coagulopathy for reasons such as accidental use of the vitamin K antagonists (VKA), excessive administration of prescribed anticoagulants of indirect action or not reported administration of vitamin K antagonists due to memory impairment and/or other mental disorders, even deliberate use thereof (attempt to murder or suicide). Rodenticide-poisoning (coumarins, warfarins) via food or occupational accidents are difficult to diagnose. This article discusses different types of acquired vitamin K-dependent coagulopathy. Differential diagnosis is primarily based on patient statements before additional causes of vitamin K deficiency are explored. Even when pathological vitamin K deficiency is not determined, appropriate and urgent medical treatment is necessary: administration of fresh frozen plasma or concentrated factors of the prothrombin complex, administration of vitamin K remedies along with symptomatic therapy. With early diagnosis and prescription of appropriate therapy, prognosis is favorable. Reasons for vitamin K antagonists-dependent coagulopathy cases.

Citing Articles

Neurobiological effects of gallic acid: current perspectives.

Bhuia M, Rahaman M, Islam T, Bappi M, Sikder M, Hossain K Chin Med. 2023; 18(1):27.

PMID: 36918923 PMC: 10015939. DOI: 10.1186/s13020-023-00735-7.


An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives.

Sharifi-Rad J, Sharopov F, Ezzat S, Zam W, Ademiluyi A, Oyeniran O High Blood Press Cardiovasc Prev. 2023; 30(2):93-107.

PMID: 36637623 DOI: 10.1007/s40292-023-00562-9.


Correcting Coagulopathy for Image-Guided Procedures.

Novelli P, Tublin J, Orons P Semin Intervent Radiol. 2022; 39(4):428-434.

PMID: 36406020 PMC: 9671671. DOI: 10.1055/s-0042-1758150.


Eryngium caeruleum: an update on ethnobotany, phytochemistry and biomedical applications.

Konovalov D, Caceres E, Shcherbakova E, Herrera-Bravo J, Chandran D, Martorell M Chin Med. 2022; 17(1):114.

PMID: 36175969 PMC: 9523986. DOI: 10.1186/s13020-022-00672-x.


Nutraceutical Profiling, Bioactive Composition, and Biological Applications of L.

Painuli S, Quispe C, Herrera-Bravo J, Semwal P, Martorell M, Almarhoon Z Oxid Med Cell Longev. 2022; 2022:2910411.

PMID: 35096265 PMC: 8791756. DOI: 10.1155/2022/2910411.


References
1.
Galvin H, Newton A, Vandeven A . Update on Munchausen syndrome by proxy. Curr Opin Pediatr. 2005; 17(2):252-7. DOI: 10.1097/01.mop.0000158729.18551.dd. View

2.
Watson W, Litovitz T, Rodgers Jr G, Klein-Schwartz W, Youniss J, Rose S . 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003; 21(5):353-421. DOI: 10.1016/s0735-6757(03)00088-3. View

3.
Saffian S, Duffull S, Roberts R, Tait R, Black L, Lund K . Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool. Ther Drug Monit. 2016; 38(6):677-683. DOI: 10.1097/FTD.0000000000000347. View

4.
Petersen D, Barthels M . [Factitious disease caused by secret administration of the oral anticoagulant phenprocoumon: study of 16 personal cases]. Med Klin (Munich). 1995; 90(5):277-83. View

5.
Kruse J, Carlson R . Fatal rodenticide poisoning with brodifacoum. Ann Emerg Med. 1992; 21(3):331-6. DOI: 10.1016/s0196-0644(05)80900-x. View